South San Francisco, CA, United States of America

Amelia Adams

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2021-2024.


% Patents Active = 100.0


 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Amelia Adams: Innovator in Cell Culture Technology

Introduction

Amelia Adams is a prominent inventor based in South San Francisco, CA (US). She has made significant contributions to the field of cell culture technology, holding a total of 2 patents. Her work focuses on the preparation of poloxamers for use in cell culture media, which has important implications for biological research and pharmaceutical development.

Latest Patents

Amelia's latest patents include innovative methods for preparing a poloxamer for use in cell culture medium. These methods provide essential techniques for creating cell culture media that contain the poloxamer, enhancing the efficiency of cell culturing and polypeptide production from cells. Her contributions in this area are vital for advancing research in cellular biology and biotechnology.

Career Highlights

Throughout her career, Amelia has worked with leading companies in the biotechnology sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to develop and refine her expertise in cell culture technologies, making her a valuable asset in the field.

Collaborations

Amelia has collaborated with notable professionals, including Robert David Kiss and Marion Glenn. These partnerships have fostered innovation and have contributed to the advancement of her research and inventions.

Conclusion

Amelia Adams is a trailblazer in the field of cell culture technology, with a focus on poloxamer preparation methods. Her patents and career achievements reflect her dedication to advancing scientific research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…